Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News scPharmaceuticals Inc SCPH

Healthcare
scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead... see more

Recent & Breaking News (NDAQ:SCPH)

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire November 8, 2023

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

GlobeNewswire November 1, 2023

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

GlobeNewswire October 31, 2023

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 5, 2023

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

GlobeNewswire September 19, 2023

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire September 5, 2023

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire August 10, 2023

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

GlobeNewswire August 3, 2023

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

GlobeNewswire August 1, 2023

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 19, 2023

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

GlobeNewswire June 23, 2023

scPharmaceuticals to Present at the Jefferies Healthcare Conference

GlobeNewswire May 31, 2023

scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire May 10, 2023

scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023

GlobeNewswire May 2, 2023

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

GlobeNewswire March 22, 2023

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22

GlobeNewswire March 15, 2023

scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference

GlobeNewswire February 23, 2023

scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)

GlobeNewswire February 21, 2023

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 6, 2023

scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

GlobeNewswire January 31, 2023